Oral disorders: Unapproved treatments or indications

Clinics in Dermatology

Volumn 18, Issue 2, 2000, Pages 197-200

  Tüzün, Binnur ^a   Tüzün, Yalçin ^b   Wolf, Ronni ^c  

^a TRAKYA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; AZATHIOPRINE; BECLOMETASONE DIPROPIONATE; BENZYDAMINE; BETAINE; BETAMETHASONE; BETAMETHASONE VALERATE; BICARBONATE; CAMPHOR; COLCHICINE; COPPER SULFATE; CORTICOSTEROID; CYCLOSPORIN; DIETHANOLAMINE; DODECYL SULFATE SODIUM; FLUORIDE; HYDROCORTISONE SODIUM SUCCINATE; IMMUNOSUPPRESSIVE AGENT; IODINE; METHOTREXATE; PEPSIN A; PROPYLENE GLYCOL; PYRALVEX; QUERCETIN; THALIDOMIDE; TRIAMCINOLONE; TRICLOSAN; UNINDEXED DRUG;

ALZHEIMER DISEASE; APHTHOUS STOMATITIS; BEHCET DISEASE; DRUG EFFICACY; DRUG INDICATION; ERYTHEMA MULTIFORME; GLYCYRRHIZA; HUMAN; LICHEN PLANUS; LUPUS ERYTHEMATOSUS; MOUTH CANCER; MOUTH DISEASE; MOUTH MUCOSA; MOUTH ULCER; PEMPHIGOID; PHARYNX CANCER; PRIORITY JOURNAL; REVIEW;

DERMATOLOGIC AGENTS; DRUG APPROVAL; FEMALE; HUMANS; MALE; MOUTH DISEASES; SENSITIVITY AND SPECIFICITY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0034603473     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00111-X     Document Type: Review

References (29)

1. Li VW, Jaffe MP, Li W, et al. Off-label dermatologic therapies: Usage risks and mechanisms. Arch Dermatol 1998; 134:1449-54.
2. Odell EW, Lim P, Bhargava R, et al. Comprehensive review of treatment for recurrent aphthous stomatitis: General comments, diagnosis and treatment selection, http:// www.umds.ac.uk/dental/opath/daphtrt1.htm 1995.
3. Wray D, Ferguson MM, Mason DK, et al. Recurrent aphthae: Treatment with vitamin B12, folic acid and iron. Br Med J 1975;2:490-3.
4. Jacobson JM, Greenspan JS, Spritzle J, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. N Engl J Med 1997;336:1487-93.
5. Yotsuyanagi T, Yamamura K, Akao Y. Mucosa-adhesive film containing local analgesic. Lancet 1985;ii:613.
6. Ruah CB, Stram JR, Chasin WD. Treatment of severe recurrent aphthous stomatitis with colchicine. Arch Otolaryngol Head Neck Surg 1988;114:671-5.
7. Birt D, From L, Main J. Diagnosis and management of long-standing benign oral ulceration. Laryngoscope 1980; 90:758-68.
8. Katz J, Langewitz P, Shemer J, et al. Prevention of recurrent aphthous stomatitis with colchicine: An open trial. J Am Acad Dermatol 1994;31:459-61.
9. Eisen D, Ellis CN. Topical cyclosporine for oral mucosal disorders. J Am Acad Dermatol 1990;23:1259-64.
10. Nethercott J, Lester RS. Azathioprine therapy in incomplete Behçet syndrome. Arch Dermatol 1974;110:432-4.
11. Hamuryudan V, Mat MC, Saip S, et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet's syndrome. A randomised, double-blind, placebo-controlled trial. Ann Intern Med 1998;128:443-50.
12. Aktulga E, Altaç M, Müftüoglu AU, et al. A double-blind study of colchicine in Behçet's disease. Haematologica 1980;65:399-402.
13. Hamuryudan V, Özyazgan Y, Hizli N, et al. Azathioprine in Behçet's syndrome: Effects on long-term prognosis. Arthritis Rheum 1997;40:769-74.
14. Yazici H, Pazarli H, Barnes CG, et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990; 322:281-5.
15. Ammann AJ, Johnson A, Fyfe GA, et al. Behçet syndrome. J Pediatr 1985;107:41-3.
16. Müftüoglu AU, Pazarli H, Yurdakul S, et al. Short-term cyclosporin A treatment of Behçet's disease. Br J Ophthalmol 1987;71:387-90.
17. Yasui K, Ohta K, Kobayashi M, et al. Successful treatment of Behçet disease with pentoxifylline. Ann Intern Med 1996;124:891-3.
18. Hamuryudan V, Özyazgan Y, Yazici H. Treatment of Behçet's disease with pentoxifylline. Ann Intern Med 1997;126:493.
19. Hamuryudan V, Yurdakul S, Rosenkaimer F, et al. Inefficacy of topical alpha-interferon in the treatment of oral ulcers of Behcet's syndrome: A randomized, double-blind trial. Br J Rheumatol 1991;30:395-6.
20. Dupin N, Chosidow O, Lunel F, et al. Oral lichen planus and hepatitis C virus infection: A fortuitous association? Arch Dermatol 1997;133:1052-3.
21. Walchner M, Messer G, Salamon N, et al. Topical tetracycline treatment of erosive oral lichen planus. Arch Dermatol 1999;135:92-3.
22. Bricker SL. Oral lichen planus: A review. Semin Dermatol 1994;13:87-90.
23. Naylor GD. Treating erosive lichen planus with griseofulvin: A report of four cases. Quintessence Int 1990;21:943-7.
24. Zegarelli DJ. The treatment of oral lichen planus. Ann Dent 1993;52:3-8.
25. Matthews RW, Scully C. Griseofulvin in the treatment of oral lichen planus: Adverse drug reactions, but little beneficial effect. Ann Dent 1992;51:10-11.
26. Johnson K. Resistant erosive lichen planus. Skin Allergy News 1998;29:23.
27. Cribier B, Frances C, Chosidow O. Treatment of lichen planus and evidence-based medicine analysis of efficacy. Arch Dermatol 1998;134:1521-30.
28. Flowers FP, Sheretz EF. Immunologic disorders of the skin and mucus membranes. Med Clin North Am 1985; 69:657-73.
29. Berk MA, Lorinez AL. The treatment of bullous pemphigoid with tetracycline and niacinamide: A preliminary report. Arch Dermatol 1986;122:670-4.